Brucellosis is a zoonotic infection caused by the bacterial genus
Brucella. Humans are accidental hosts, but brucellosis continues to be an important public health problem worldwide, which reflects spreading of disease in animals (
1,
2). Fever is the most common symptom. It is associated with chills in almost 80% of patients. Constitutional symptoms of brucellosis are very common (> 90%) and include anorexia, malaise, fatigue, weakness, and weight loss. Other common clinical symptoms include low back pain, joint pain, and rarely, joint swelling. These symptoms affect as many as 50% to 80% of patients. Arthralgias may be diffuse or localized, with a predilection for epiphysis and the sacroiliac joint (
1-
3). Brucellosis should be considered in any patient whose place of residence, dietary, and occupational history suggests a risk for the infection and in those who are experiencing any of the various known neurological or non-neurological complications in brucellosis endemic areas. Neurobrucellosis is a rare and severe form of systemic infection and has a broad range of clinical syndromes. The most frequent clinical syndromes associated with brucellosis are meningitis or meningoencephalitis (
2-
4). Encephalomyelitis is a general term for inflammation of the CNS, describing a number of disorders and acute disseminated encephalomyelitis. MS is a demyelinating disease of the CNS, which is possibly triggered by infection (mostly viral), stress, smoking, autoimmune disorders, and genetic factor (
5-
9). A patient with MS can have almost any neurological sign or symptom including motor, sensory, and visual problems, which are the most common presentation. The specific symptoms are related to the locations of the lesions within CNS. These symptoms may be loss of sensitivity or changes in sensation such as pins and needles or numbness, muscle spasms, muscle weakness, or difficulty in moving and coordination. Visual problems such as nystagmus, optic neuritis, or double vision can be seen (
5,
6). Many rare complications of neurobrucellosis have been reported (
2-
4,
10). Yilmaz et al. reported a case of neurobrucellosis with hydrocephaly (
2). Tugcu et al. reported a case of chronic meningitis due to brucellosis leading to complicated intracranial hypertension (
3). Bektas et al. presented a case of neurobrucellosis that similar to our patient, presented as demyelination disorder (
4). Sometimes neurobrucellosis complication can present as an acute disseminated encephalomyelitis. On the other hand, some of the signs and symptoms of brucellosis can mimic MS manifestations. This condition in our patient could be a comorbidity of brucellosis and MS due to another cause or MS can present as a systemic complication of brucellosis. Our patient responded to antimicrobial agents. However, according to neurology consultation, we started high-dose steroid too. We conclude that brucellosis should be considered in any patient who is experiencing any of the various known neurologic or complications of brucellosis in endemic areas.